AIMS: To report outcome on patients over 80years of age with soft tissue sarcoma (STS), with respect to surgical treatment, co-morbidity, complications and survival. METHODS From a prospective database of 3400 patients with STS presenting over a 13-year period, all patients over 80years of age were identified and reviewed, with respect to tumour characteristics morbidity, mortality and outcome. RESULTS 128 patients over 80years were treated for STS with 63 referred for treatment of primary disease, of whom 50 underwent resectional surgery. The remaining 65 patients were treated for recurrent or incompletely excised disease. Of the 50 patients treated primarily with surgery, 56% of tumours where high grade and 56% were greater than 10cm in d...
International audienceTo evaluate short- and long-term results after curative surgery for a retroper...
This report is based on 1.851 adult patients with soft tissue sarcoma (STS) of the extremities or tr...
Background: Incidences of soft tissue sarcomas (STS) steadily increase with age. Yet, despite the hi...
Background: There are no data regarding the management of advanced soft-tissue sarcoma (STS) in elde...
Background: The population of many countries is aging and a significant number of elderly patients w...
The present study evaluates the outcomes and prognostic factors in patients with soft-tissue sarcoma...
Nearly half of soft-tissue sarcoma (STS) patients are over the age of 65, and the behavior of cancer...
International audienceSoft tissue sarcomas (STS) are rare tumors accounting for less than 1% of huma...
Background: To study the management patternof soft tissue sarcomas in a tertiary care settingMethods...
Objective. To describe real-world treatment patterns and outcomes for patients with advanced soft ti...
PURPOSE: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 year...
International audienceTo evaluate short- and long-term results after curative surgery for a retroper...
This report is based on 1.851 adult patients with soft tissue sarcoma (STS) of the extremities or tr...
Background: Incidences of soft tissue sarcomas (STS) steadily increase with age. Yet, despite the hi...
Background: There are no data regarding the management of advanced soft-tissue sarcoma (STS) in elde...
Background: The population of many countries is aging and a significant number of elderly patients w...
The present study evaluates the outcomes and prognostic factors in patients with soft-tissue sarcoma...
Nearly half of soft-tissue sarcoma (STS) patients are over the age of 65, and the behavior of cancer...
International audienceSoft tissue sarcomas (STS) are rare tumors accounting for less than 1% of huma...
Background: To study the management patternof soft tissue sarcomas in a tertiary care settingMethods...
Objective. To describe real-world treatment patterns and outcomes for patients with advanced soft ti...
PURPOSE: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 year...
International audienceTo evaluate short- and long-term results after curative surgery for a retroper...
This report is based on 1.851 adult patients with soft tissue sarcoma (STS) of the extremities or tr...
Background: Incidences of soft tissue sarcomas (STS) steadily increase with age. Yet, despite the hi...